Lymphoma Trial, Recruiting NCT05201534 Sponsor: Stanford University Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT05201534
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children in primary school from first grade onwards, between 6 and 12 years old
  • Children whose IQ score is above 70, as measured by a standard intelligence test called the WASI-II
  • Children identified as having a mathematical learning disability, meaning scores below the 35th percentile on a number processing screening test, and low scores on two or more sections of a standardised math achievement test (WIAT-IV)
  • Children identified as typically developing in math, meaning scores at or at or above the 35th percentile on the number processing screening test, and typical scores across all sections of the math achievement test (WIAT-IV)
  • Children with normal vision, or vision that is fully corrected with glasses or contact lenses, and no hearing problems
  • Children who are right-handed (this applies to the MRI scan part of the study)

Who may not be able to join:

  • Children with a history of a neurological or psychiatric condition, such as schizophrenia, psychosis, depression, or ADHD
  • Children who have had a head injury in the past
  • Children who are currently taking psychiatric medications on a regular basis
  • Children who have reasons they cannot safely have an MRI scan, such as having braces, metal implants, a pacemaker, vascular stents, metal ear tubes, regular exposure to metal, or claustrophobia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 16507363699

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 May 2023
Est. completion
31 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from baseline in symbolic number comparison task performance (reaction time); Change from baseline in symbolic number comparison task performance (accuracy); Change from baseline in non-symbolic number comparison task performance (reaction time); Change from baseline in non-symbolic number comparison task performance (accuracy); Change from baseline in latent cognitive measures of symbolic number comparison task performance (drift rate); Change from baseline in latent cognitive measures of symbolic number comparison task performance (post-error adjustment); Change from baseline in laten...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov